The disorder caused by the substitution of Glutamic acid (Glu) by Valine (Val) at the sixth position of the beta globin chain of the hemoglobin is known as Sickle-cell Anemia.
In the normal beta-globin chain of hemoglobin, the sixth amino acid is Glutamic acid. In Sickle-cell Anemia, due to a genetic mutation, Glutamic acid is replaced by Valine. This substitution leads to the production of abnormal hemoglobin known as hemoglobin S (HbS).
Explanation of the mutation process:
This genetic disorder illustrates the importance of amino acid sequencing in protein function and the profound impact that a single amino acid substitution can have on overall health.
Sickle-cell anemia is a genetic disorder caused by a mutation in the beta-globin gene of hemoglobin. Specifically, it involves the substitution of the amino acid glutamic acid (Glu) with valine (Val) at the sixth position of the beta-globin chain. This small change leads to the formation of abnormal hemoglobin, known as hemoglobin S (HbS), which causes red blood cells to adopt a sickle shape, leading to reduced oxygen-carrying capacity and blockages in blood vessels.
List-I (Disease) | List-II (Pathogen/Genera) |
(A) Amoebiasis | (I) Wuchereria |
(B) Filariasis | (II) Entamoeba histolytica |
(C) Ringworm | (III) Haemophilus influenzae |
(D) Pneumonia | (IV) Epidermophyton |